Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer

Active, not recruiting

• Conditions: Early Stage Breast Carcinoma

• Registration Number: NCT06387173
• Lead Sponsor: Jonsson Comprehensive Cancer Center

Brief Summary

This study evaluates the side effects and outcomes of patients who undergo cryoablation for early stage breast cancer.

Detailed Description

PRIMARY OBJECTIVE:

I. To obtain observational real-life data of patients who choose this non-conventional treatment and to follow their outcomes.

OUTLINE: This is an observational study.

Patients have their medical records reviewed on study.

Study Timeline

• Study Start: 2024-01-04
• Study First Submitted: 2024-03-25
• Study First Submitted QC: 2024-04-23
• Study First Posted: 2024-04-26
• Primary Completion: 2025-01-03
• Status Verified: 2025-04
• Last Update Submitted: 2025-04-10
• Last Update Posted: 2025-04-15
• Study Completion: 2099-01-03

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 2

Inclusion Criteria

• Patients undergoing cryoablation for breast cancer

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prospectively track patients who undergo cryoablation for breast cancer and record post-treatment related events.	five years from last participant enrollment	record follow up of symptoms, reported complications, breast imaging findings, and results of any future biopsies related to cancer, and treatment of breast cancer.

Trial Locations

Locations (1)

UCLA / Jonsson Comprehensive Cancer Center; 🇺🇸 Los Angeles, California, United States